Changbin Zhu
Changbin Zhu publishes mostly in Oncology, Molecular Biology and Cancer Research, on topics such as Cancer Genomics and Diagnostics, Lung Cancer Treatments and Mutations and PARP inhibition in cancer therapy.
- World rank
- #1,190,936 of 7,710,434 ranked researchers
- Rank in China
- #172,091 of 978,568
- Works
- 85
- Citations
- 1.1k
- Citations per work
- 13.2
What does Changbin Zhu research?
Changbin Zhu's work is mostly in Medicine (32%), Biochemistry, Genetics and Molecular Biology (30%), Immunology and Microbiology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences3135.9%
- Health Sciences2732.1%
- Medicine2732.1%
- Everything else2732.0%
- 1Oncology19% of their works
- 2Molecular Biology13% of their works
- 3Cancer Research13% of their works
- 4Pulmonary and Respiratory Medicine13% of their works
- 5Immunology6% of their works
- 6Genetics4% of their works
Research topics
Which keywords describe Changbin Zhu's research?
The keywords of their largest research topics: Targeted Therapy, Clinical Trials, Cancer Genomics, Mutational Signatures, Cancer Risk, Genetic Testing, ALK Inhibitors and EGFR Mutations.
- Small-Cell Lung Cancer
- Microsatellite Instability
- Genomic Profiles
- BRCA1
- PD-1 and PD-L1
- PARP Inhibitors
- EGFR Mutations
- Genetic Testing
- Mutational Signatures
- Clinical Trials
- Targeted Therapy
- Cancer Genomics
- Cancer Risk
- ALK Inhibitors
- BRCA Mutation
- Immune Checkpoint Blockade
- Activation
- BRCA2
- Macrophage
- Molecular Characterization
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 20 words, with their numbers
- Targeted Therapy473 topics
- Clinical Trials262 topics
- Cancer Genomics211 topic
- Mutational Signatures211 topic
- Cancer Risk182 topics
- Genetic Testing182 topics
- ALK Inhibitors171 topic
- EGFR Mutations171 topic
- BRCA Mutation121 topic
- PARP Inhibitors121 topic
- Immune Checkpoint Blockade101 topic
- PD-1 and PD-L1101 topic
- Activation91 topic
- BRCA191 topic
- BRCA291 topic
- Genomic Profiles91 topic
- Macrophage91 topic
- Microsatellite Instability91 topic
- Molecular Characterization91 topic
- Small-Cell Lung Cancer91 topic
Where does Changbin Zhu work?
Changbin Zhu's main affiliation in the publication record is Dian Diagnostics (China), China.
How many publications and citations does Changbin Zhu have?
OpenAlex counts 85 works and 1,120 citations for Changbin Zhu, an h-index of 18, ranking #1,190,936 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Changbin Zhu. Posts are plain text and can be reported.